Help Patients With Skyrocketing Insulin Costs
One in four patients with diabetes will ration or even stop their insulin due to skyrocketing costs...sometimes leading to death.
In the U.S., only 3 companies make insulin...driving up prices.
You'll see more efforts to address costs...such as co-pay caps from some payers and states. And FDA is exploring ways to promote competition.